We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKX
1526
DELISTED
Skechers
SKX
| $9M | ﹤0.01% |
283,763
-5,903
| -2% | -$221K |
|
1527
Broadstone Net Lease
BNL
$4.02B
| $8.98M | ﹤0.01% |
578,539
-1,202,810
| -68% | -$24.4M |
|
1528
Unifirst Corp
UNF
$5.25B
| $8.98M | ﹤0.01% |
53,369
-1,149
| -2% | -$210K |
|
1529
DigitalOcean
DOCN
$14.6B
| $8.93M | ﹤0.01% |
246,943
-158,805
| -39% | -$6.68M |
|
|
EQC
1530
DELISTED
Equity Commonwealth
EQC
| $8.92M | ﹤0.01% |
366,218
-10,794
| -3% | -$290K |
|
|
AAWW
1531
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $8.92M | ﹤0.01% |
93,336
-1,991
| -2% | -$176K |
|
1532
Maravai LifeSciences
MRVI
$919M
| $8.91M | ﹤0.01% |
349,096
-16,496
| -5% | -$414K |
|
1533
Itron
ITRI
$4.54B
| $8.91M | ﹤0.01% |
211,532
-5,834
| -3% | -$290K |
|
1534
Fulton Financial
FULT
$4.64B
| $8.9M | ﹤0.01% |
563,215
-690
| -0.1% | -$11.1K |
|
|
AVNS
1535
DELISTED
Avanos Medical
AVNS
| $8.89M | ﹤0.01% |
408,078
-188,057
| -32% | -$4.91M |
|
|
ARCH
1536
DELISTED
Arch Resources, Inc.
ARCH
| $8.88M | ﹤0.01% |
74,873
-1,048
| -1% | -$145K |
|
1537
Ginkgo Bioworks
DNA
$521M
| $8.85M | ﹤0.01% |
70,885
+30,979
| +78% | +$3.69M |
|
1538
Ralph Lauren
RL
$23.6B
| $8.84M | ﹤0.01% |
104,082
-2,972
| -3% | -$280K |
|
1539
Cinemark Holdings
CNK
$4.32B
| $8.83M | ﹤0.01% |
729,153
+9,238
| +1% | +$145K |
|
1540
Excelerate Energy
EE
$1.11B
| $8.78M | ﹤0.01% |
375,157
+7,431
| +2% | +$176K |
|
1541
National Health Investors
NHI
$3.65B
| $8.77M | ﹤0.01% |
155,165
-5,217
| -3% | -$329K |
|
|
MZTI
1542
The Marzetti Company
MZTI
$3.11B
| $8.76M | ﹤0.01% |
58,284
-635
| -1% | -$94.2K |
|
1543
Procore
PCOR
$8.67B
| $8.74M | ﹤0.01% |
176,729
-5,739
| -3% | -$309K |
|
1544
Federal Agricultural Mortgage
AGM
$2.56B
| $8.73M | ﹤0.01% |
88,011
-1,053
| -1% | -$112K |
|
|
RDUS
1545
DELISTED
Radius Recycling
RDUS
| $8.72M | ﹤0.01% |
306,378
+11,594
| +4% | +$389K |
|
1546
Cimpress
CMPR
$2.31B
| $8.71M | ﹤0.01% |
355,628
-202,052
| -36% | -$6.91M |
|
1547
MSC Industrial Direct
MSM
$6.86B
| $8.7M | ﹤0.01% |
119,463
+23
| +0% | +$1.81K |
|
1548
Medifast
MED
$141M
| $8.68M | ﹤0.01% |
80,132
+4,284
| +6% | +$614K |
|
1549
Alight
ALIT
$407M
| $8.68M | ﹤0.01% |
59,221
-1,640
| -3% | -$253K |
|
1550
Meritage Homes
MTH
$4.86B
| $8.68M | ﹤0.01% |
246,922
-6,804
| -3% | -$275K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.